Fred Brown has been assisting 17 U.S. state governments, 5 national governments, several US agencies, 2 NGO’s, and selected mayors with their COVID response at no charge during this outbreak – decision makers responsible for the health of over 2 billion people.
Fred comes to the fight against COVID-19 from a forty-year career developing pharmaceutical solutions to fight infectious diseases and solve the myriad challenges involved in suppressing epidemics including HIV, H5N1, Ebola, Zika, measles, malaria and others.
Fred Brown has been assisting 17 U.S. state governments, 5 national governments, several US agencies, 2 NGO’s, and selected mayors with their COVID response at no charge during this outbreak – decision makers responsible for the health of over 2 billion people.
Fred comes to the fight against COVID-19 from a forty-year career developing pharmaceutical solutions to fight infectious diseases and solve the myriad challenges involved in suppressing epidemics including HIV, H5N1, Ebola, Zika, measles, malaria and others.
Epidemic Intervention
- Developing and commercializing first test for HIV (Centocor/
DuPont). - Managing Roche Diagnostics and Tamiflu suppression of H5N1
Influenza.
Pharmaceutical Development
- Led or supported the discovery, development and/or launch of 27 pharmaceutical, 13 diagnostic and 6 vaccine products.
- Global Head, Hoffmann LaRoche Product Lifecycle,
Partnerships and Informatics.
Health Policy and Technology Management
- Founded and led the Healthcare and Life Sciences Divisions of Andersen Consulting (Accenture) and IBM in the US, and in EU, Middle East and Africa (EMEA).
- Co-founder of Alkermes (NASDAQ: ALKS). Member, Boards of Directors of several venture-backed device, diagnostic, healthcare and therapeutic companies.
- President of the largest independent specialty pharmacy and Head of Innovation and Growth at the largest not-for-profit hospital system.
DETAIL
-
EXPERIENCED
Trained as a medicinal biochemist, Fred has been on the discovery, development and/or launch teams of 27 major pharmaceutical, 13 diagnostic, and 6 vaccine products. Collectively, these products save the lives of over 5.6 million people annually and generated over $35B of revenue in 2020. His extensive experience managing past pandemics are now accelerating and supporting personal, business and government responses to COVID-19 around the world. -
SKILLED
Fred has an unmatched ability to integrate his experience and education with analyses of data from medical, scientific, and economic sources, and help leaders interpret the data to develop effective action plans. Fred has been assisting 17 U.S. state governments, 5 national governments, several agencies, 2 NGO’s and selected mayors with their COVID response at no charge during this outbreak. -
UNBIASED
Unlike many people with academic, medical and pharmaceutical credentials, Fred is fortunate to be self-employed, and can speak his mind without regard to constraints imposed by an employer or affiliated institution. His motivation to engage full-time with this pandemic crisis is a deep understanding, experience set, and personal desire to help solve it; he has no commercial interests to advance. -
EDUCATION
Tufts University, B.S. 1981, Magna Cum Laude, Biology and Geology. Harvard University, MBA, 1985. -
AFFILIATIONS
Johns Hopkins Medical School/ES4P, Board Member of Continuing Medical Education. University of Michigan, Adjunct Faculty and Social Venture Fund, Health Sector Lead. Board Member, PreDxion Biosciences and Warmilu, Inc.
I see myself as a truth-telling antigen, trying to stimulate the
world’s immune system to respond more robustly to the threat. My goal is to help people think clearly about the huge issues raised by the COVID-19 pandemic.
– Fred Brown